Q5113 Injection herzuma 10 milligrams
Also known as: Herzuma injection, trastuzumab-pkrb
Injection of Herzuma, trastuzumab-pkrb biosimilar per 10 milligrams, for HER2-positive malignancies.
In Plain Language
HER2-targeted cancer drug; breast cancer therapy
Clinical Context
Indicated for HER2-positive breast and gastric cancers requiring targeted antibody therapy.
RVU Information
CPT Q5113 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Q-codes are temporary HCPCS codes used when no permanent code exists. Coverage and reimbursement vary by payer and region. Document the clinical indication and medical necessity. These codes may be replaced by permanent codes in future HCPCS updates.
Specialties
Frequently Asked Questions
What is CPT code Q5113?
CPT Q5113 (Injection herzuma 10 milligrams) is a Q Codes code. Injection of Herzuma, trastuzumab-pkrb biosimilar per 10 milligrams, for HER2-positive malignancies.
Is Q5113 covered by insurance?
Q5113 is a temporary HCPCS code. Coverage varies by payer and may change when permanent codes are assigned. Indicated for HER2-positive breast and gastric cancers requiring targeted antibody therapy.
When is CPT Q5113 used?
Indicated for HER2-positive breast and gastric cancers requiring targeted antibody therapy.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.